Glucocorticoid Replacement and Mortality in Patients with Nonfunctioning Pituitary Adenoma
Data(s) |
2012
|
---|---|
Resumo |
Current treatment guidelines generally suggest using lower and weight-adjusted glucocorticoid replacement doses in patients with insufficiency of the hypothalamic-pituitary-adrenal (HPA) axis. Although data in patients with acromegaly revealed a positive association between glucocorticoid dose and mortality, no comparable results exist in patients with nonfunctioning pituitary adenomas (NFPA). |
Formato |
application/pdf |
Identificador |
http://boris.unibe.ch/9375/1/Zueger%20JClinEndocrinolMetab%202012.pdf Zueger, Thomas; Kirchner, Paul; Herren, Coline; Fischli, Stefan; Zwahlen, Marcel; Christ, Emanuel; Stettler, Christoph (2012). Glucocorticoid Replacement and Mortality in Patients with Nonfunctioning Pituitary Adenoma. Journal of clinical endocrinology and metabolism, 97(10), E1938-42. Chevy Chase, Md.: Endocrine Society 10.1210/jc.2012-2432 <http://dx.doi.org/10.1210/jc.2012-2432> doi:10.7892/boris.9375 info:doi:10.1210/jc.2012-2432 info:pmid:22872686 urn:issn:0021-972X |
Idioma(s) |
eng |
Publicador |
Endocrine Society |
Relação |
http://boris.unibe.ch/9375/ |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
Zueger, Thomas; Kirchner, Paul; Herren, Coline; Fischli, Stefan; Zwahlen, Marcel; Christ, Emanuel; Stettler, Christoph (2012). Glucocorticoid Replacement and Mortality in Patients with Nonfunctioning Pituitary Adenoma. Journal of clinical endocrinology and metabolism, 97(10), E1938-42. Chevy Chase, Md.: Endocrine Society 10.1210/jc.2012-2432 <http://dx.doi.org/10.1210/jc.2012-2432> |
Palavras-Chave | #610 Medicine & health |
Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion NonPeerReviewed |